» Articles » PMID: 34068687

Sexual Dimorphism in Body Weight Loss, Improvements in Cardiometabolic Risk Factors and Maintenance of Beneficial Effects 6 Months After a Low-Calorie Diet: Results from the Randomized Controlled DiOGenes Trial

Overview
Journal Nutrients
Date 2021 Jun 2
PMID 34068687
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A low-calorie diet (LCD) is an effective strategy to lose weight and improve cardiometabolic risk factors, however, sexual dimorphism may be present. This study aims to investigate sexual dimorphism in cardiometabolic risk factors following weight loss and after weight maintenance. 782 overweight/obese participants (65% women) of the DiOGenes trial followed an 8-week LCD (~800 kcal/day), with a 6-months follow-up weight maintenance period on diets varying in protein content and glycemic index. Men lost more body weight during the LCD period (-12.8 ± 3.9 vs. -10.1 ± 2.8 kg, respectively, < 0.001), but regained more weight during the follow-up period than women (1.5 ± 5.4 vs. -0.5 ± 5.5 kg, respectively, < 0.001). Even though beneficial LCD-induced changes in cardiometabolic risk factors were found for both sexes, improvements in HOMA-IR, muscle and hepatic insulin sensitivity, triacylglycerol, HDL-, LDL- and total cholesterol, diastolic blood pressure, cholesterol esters, sphingomyelins and adiponectin were more pronounced in men than women (std. ß range: 0.073-0.144, all < 0.05), after adjustment for weight change. During follow-up, women demonstrated a lower rebound in HDL-cholesterol, triacylglycerol and diacylglycerol (std. ß range: 0.114-0.164, all < 0.05), independent of changes in body weight. Overall, we demonstrated sexual dimorphism in LCD-induced changes in body weight and cardiometabolic risk profile, which may be attributed to differences in body fat distribution and metabolic status.

Citing Articles

Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging Therapies.

Dileo E, Saba F, Parasiliti-Caprino M, Rosso C, Bugianesi E Nutrients. 2025; 17(3).

PMID: 39940335 PMC: 11821005. DOI: 10.3390/nu17030477.


NK2R control of energy expenditure and feeding to treat metabolic diseases.

Sass F, Ma T, Ekberg J, Kirigiti M, Urena M, Dollet L Nature. 2024; 635(8040):987-1000.

PMID: 39537932 PMC: 11602716. DOI: 10.1038/s41586-024-08207-0.


Sex-Specific Variation in Metabolic Responses to Diet.

Andrews R, Anderson K, Fry J Nutrients. 2024; 16(17).

PMID: 39275236 PMC: 11397081. DOI: 10.3390/nu16172921.


Comparison of the impact of longitudinal body mass index changes on cardiac arrest risk between normal and overweight populations.

Kim Y, Kim M, Kim Y, Kim W J Cachexia Sarcopenia Muscle. 2024; 15(4):1616-1620.

PMID: 38887918 PMC: 11294010. DOI: 10.1002/jcsm.13504.


Relationship between Atherogenic Dyslipidaemia and Lipid Triad and Scales That Assess Insulin Resistance.

Paublini H, Lopez Gonzalez A, Busquets-Cortes C, Tomas-Gil P, Riutord-Sbert P, Ramirez-Manent J Nutrients. 2023; 15(9).

PMID: 37432258 PMC: 10180556. DOI: 10.3390/nu15092105.


References
1.
Anderson J, Konz E, Frederich R, Wood C . Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001; 74(5):579-84. DOI: 10.1093/ajcn/74.5.579. View

2.
Barber M, Risis S, Yang C, Meikle P, Staples M, Febbraio M . Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One. 2012; 7(7):e41456. PMC: 3405068. DOI: 10.1371/journal.pone.0041456. View

3.
Machann J, Thamer C, Stefan N, Schwenzer N, Kantartzis K, Haring H . Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology. 2010; 257(2):353-63. DOI: 10.1148/radiol.10092284. View

4.
Kwon H, Kim D, Kim J . Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study. Sci Rep. 2017; 7(1):10955. PMC: 5591218. DOI: 10.1038/s41598-017-09723-y. View

5.
Vogelzangs N, van der Kallen C, van Greevenbroek M, van der Kolk B, Jocken J, Goossens G . Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study. Int J Obes (Lond). 2020; 44(6):1376-1386. DOI: 10.1038/s41366-020-0565-z. View